Sweet Hope for Type 1 Diabetics [link]

Immune Tolerance Institute Announces Collaboration with Beckman Coulter Establishing a Multiplatform Immunophenotyping/Immunogenotyping Laboratory [link]

Doctors report transplant breakthrough in ITN study [read]

Statement of Griffin P. Rodgers, M.D., Director, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, on World Diabetes Day [read]

GlaxoSmithKline And Tolerx Form Worldwide Collaboration For Development And Commercialization Of TRX4 [read]

Lilly and MacroGenics Announce Licensing and Collaboration Agreement for Anti-CD3 [read]

CD4+CD25+FOXP3+ Regulatory T Cells Increase De Novo in Kidney Transplant Patients After Immunodepletion with Campath-1H - Am J Transplant [read]

A longitudinal analysis of SLE patients treated with rituximab (anti-CD20): Factors associated with B lymphocyte recovery - Clin Immunol [read]

Murine Antithymocyte Globulin Therapy Alters Disease Progression in NOD Mice by a Time-Dependent Induction of Immunoregulation - Diabetes [read]

HLA-mismatched renal transplantation without maintenance immunosuppression - NEJM [read]

Chimerism and tolerance in a recipient of a deceased-donor liver transplant - NEJM [read]

more publications...

Just a few of the accomplishments of the ITN and its investigators.
[Adobe .pdf, 545 kb]

A detailed report on ITN research activities.
[Adobe .pdf, 1.6 MB]

    Clinical Trial Enrollment Pages
    ITN Tolerance Gene List
    "Who to Ask" at the ITN
    Subscribe to the ITN Mailing List